• Abeona Therapeutics reported the resignation of director Michael Amoroso, effective immediately on June 11, 2026.
• Amoroso also stepped down from the board’s Nominating and Corporate Governance Committee.
• The departure was attributed to personal reasons, not to any disagreement over company operations, policies, or practices.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abeona Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-028369), on June 12, 2026, and is solely responsible for the information contained therein.